Science Market Update

$8.5M in Life Science Funding Awarded to UNC Chapel Hill

Posted by Jennifer Nieuwkerk on Fri, Nov 01, 2013

“Despite the clinical success of antiretroviral therapy (ART), more people contract human immunodeficiency virus (HIV) infection daily than initiate ART,” states the NIH RePORTER abstract for a new study receiving funding from the NIH. “The difficulties of lifelong ART - particularly in the developing world - make the eradication of HIV imperative. But clearance of a retroviral infection for patients on ART is a herculean task. While much is known about HIV persistence despite ART, many puzzles remain. New tools to address latent infection must replace the paradigms and models used to develop ART.”

Read More

Tags: 2014, University of North Carolina, Southern, Front Line event, NC, Chapel Hill, NIH funding, NIH grant, NIH award, UNC, NC State

NC State Chemistry Researchers Find Compound Effective Against NDM-1

Posted by Jennifer Nieuwkerk on Wed, Mar 07, 2012

A dangerous situation presents itself when bacteria evolve defenses against antibiotics. Experience has shown us that it can be a discouraging catastrophe for public health when a new drug-resistant strain, or a gene that confers resistance, shows up in a new place, as happened when the NDM-1 gene (which is resistant to up to 14 drugs) showed up in New Delhi drinking water. Scientists are searching for a way to defeat that debilitating resistance, however, and every so often there's encouraging news: On February 4, North Carolina State University chemistry researchers published a study in which they said that they’ve found a molecule that makes antibiotics 16 times more effective against recently identified antibiotic-resistant “superbugs.”

Read More

Tags: North Carolina, Northeast, BRPF, public health, North Carolina State University, NC State, chemistry researchers, Front Line event

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News